Skip to main content

Advertisement

SpringerLink
Log in

Modifiable cardiovascular risk factors in patients with ankylosing spondylitis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate whether modifiable cardiovascular disease (CVD) risk factors, e.g. atherogenic blood lipids, hypertension and lifestyle-related factors such as smoking, diet and physical inactivity, differ among patients with ankylosing spondylitis (AS) in comparison to the general population. Eighty-eight patients diagnosed with AS were identified by analysis of the databases of a previous community intervention programme, the Västerbotten intervention programme. The patients were compared with 351 controls matched for age, sex and study period. These databases include the results of blood samples analysed for cholesterol, triglycerides and plasma glucose, as well as data on hypertension, height, weight, smoking and dietary habits and physical activity. No significant differences were found between patients and controls regarding hypertension, body mass index, physical activity, diet or smoking. Levels of serum triglycerides (p < 0.01) and cholesterol (p < 0.01) were significantly lower in the patient group. Among the patients, the level of triglycerides correlated inversely with the intake of total fat (r s = −0.25, p < 0.05), monounsaturated fats (r s = −0.29, p < 0.05) and positively correlated to the intake of carbohydrates (r s = 0.26, p < 0.05). These associations were not apparent among the controls. In the cohort of AS patients studied, no differences were found regarding the modifiable risk factors for CVD compared with the general population. Hence, the increased presence of CVD in patients with AS may be caused by other factors such as differences in metabolism and medication such as NSAID or the chronic low-grade inflammation present in the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kinsella TD, MacDonald FR, Johnson LG (1966) Ankylosing spondylitis: a late re-evaluation of 92 cases. Can Med Assoc J 95:1

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Bulkley BH, Roberts WC (1973) Ankylosing spondylitis and aortic regurgitation: description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 48:1014–1027

    Article  CAS  PubMed  Google Scholar 

  3. Roldan CA, Chavez J, Wiest PW, Qualls CR, Crawford MH (1998) Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 32:1397–1404

    Article  CAS  PubMed  Google Scholar 

  4. Dik VK, Peters MJ, Dijkmans PA et al (2010) The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol 39:38–41

    Article  CAS  PubMed  Google Scholar 

  5. Han C, Robinson DWJ, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172

    PubMed  Google Scholar 

  6. Hollan I, Saatvedt K, Almdahl SM et al (2008) Spondyloarthritis: a strong predictor of early coronary artery bypass grafting. Scand J Rheumatol 37:18–22

    Article  CAS  PubMed  Google Scholar 

  7. Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70:1921–1925

    Article  PubMed  Google Scholar 

  8. van Dam RM, Li T, Spiegelman D, Franco OH, Hu FB (2008) Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ 337:a1440

    Article  PubMed Central  PubMed  Google Scholar 

  9. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–52

    Article  PubMed  Google Scholar 

  10. Hahn BH, Grossman J, Chen W, McMahon M (2007) The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28:69–75

    Article  CAS  PubMed  Google Scholar 

  11. Weinehall L, Hellsten G, Boman K, Hallmans G (2001) Prevention of cardiovascular disease in Sweden: the Norsjo community intervention programme—motives, methods and intervention components. Scand J Public Health Suppl 56:S13–20

    Google Scholar 

  12. Norberg M, Wall S, Boman K, Weinehall L (2010) The vasterbotten intervention programme: background, design and implications. Glob Health Action 3:4643

    Google Scholar 

  13. Weinehall L, Hallgren CG, Westman G, Janlert U, Wall S (1998) Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care 16:171–6

    Article  CAS  PubMed  Google Scholar 

  14. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–8

    Article  PubMed  Google Scholar 

  15. Johansson I, Hallmans G, Wikman A, Biessy C, Riboli E, Kaaks R (2002) Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort. Public Health Nutr 5:487–96

    Article  PubMed  Google Scholar 

  16. Johansson I, Van Guelpen B, Hultdin J, Johansson M, Hallmans G, Stattin P (2010) Validity of food frequency questionnaire estimated intakes of folate and other B vitamins in a region without folic acid fortification. Eur J Clin Nutr 64:905–913

    Article  CAS  PubMed  Google Scholar 

  17. Bergström L, Hagman U, Eriksson H, Bruce Å (1991) The food composition data base system (KOST systemet)—its use for nutrient values [Swedish]. Vår Föda 43:439–47

    Google Scholar 

  18. Johansson G, Westerterp KR (2008) Assessment of the physical activity level with two questions: validation with doubly labeled water. Int J Obes 32:1031–3

    Article  CAS  Google Scholar 

  19. Schofield WN (1985) Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 39(Suppl 1):5–41

    PubMed  Google Scholar 

  20. Johansson G, Åkesson Å, Nermell B, Berglund M, Vahter M (1998) Validation with biological markers for food intake of a dietary assessment method used by Swedish women with three different dietary preferences. Public Health Nutr 1:199–206

    Article  CAS  PubMed  Google Scholar 

  21. Johansson G, Wikman A, Ahrén AM, Hallmans G, Johansson I (2001) Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living. Public Health Nutr 4:919–927

    Article  CAS  PubMed  Google Scholar 

  22. Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr Suppl 65:1220S–8S

    CAS  Google Scholar 

  23. Kang JH, Chen YH, Lin HC (2010) Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis 69(6):1165–8

    Article  PubMed  Google Scholar 

  24. Bremander A, Petersson IF, Bergman S, Englund M (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 63:550–556

    Article  Google Scholar 

  25. Mathieu S, Gossec L, Dougados M, Soubrier M (2011) Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:557–563

    Article  Google Scholar 

  26. Sundström B, Wållberg-Jonsson S, Johansson G (2010) Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis. Clin Rheumatol 30:71–6

    Article  PubMed  Google Scholar 

  27. Sundström B, Johansson G, Kokkonen H, Cederholm T, Wållberg-Jonsson S (2012) Plasma phospholipid fatty acid content is related to disease activity in ankylosing spondylitis. J Rheumatol 39:327–33

    Article  PubMed  Google Scholar 

  28. van Halm VP, van Denderen JC, Peters MJ, Twisk JW, van der Paardt M, van der Horst-Bruinsma IE et al (2006) Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 65:1473–7

    Article  PubMed  Google Scholar 

  29. Divecha H, Sattar N, Rumley A, Cherry L, Lowe GD, Sturrock R (2005) Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 109:171–6

    Article  CAS  Google Scholar 

  30. McCarey D, Sturrock RD (2009) Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol Suppl 27:S124–6

    CAS  Google Scholar 

  31. Hu FB, Willett WC (2002) Optimal diets for prevention of coronary heart disease. JAMA 288:2569–78

    Article  CAS  PubMed  Google Scholar 

  32. Rall LC, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford) 43:1219–23

    Article  CAS  Google Scholar 

  33. Staal-van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF (1995) Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 13:2600–5

    CAS  PubMed  Google Scholar 

  34. Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442–52

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge Sonja Odeblom for skilful administrative help. Åsa Ågren and Anna-Sara Molin at Northern Sweden Medical Research Bank are thanked for help in gaining access to the data. This work was supported by grants from the northern county councils Visare Norr, the Borgerskapet fund in Umeå, the Department of Research Norrbotten county council and the Swedish Rheumatism Association.

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Public Health and Clinical Medicine, Rheumatology, Umeå University, Umeå, Sweden

    Björn Sundström & Solveig Wållberg-Jonsson

  2. School of Social and Health Sciences, Halmstad University, Halmstad, Sweden

    Gunnar Johansson

  3. Department of Odontology, Cariology, Umeå University, Umeå, Sweden

    Ingegerd Johansson

  4. Department of Public Health and Clinical Medicine, Rheumatology, University Hospital, 90185, Umeå, Sweden

    Björn Sundström

Authors
  1. Björn Sundström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunnar Johansson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ingegerd Johansson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Solveig Wållberg-Jonsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Björn Sundström.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Table 1

(DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sundström, B., Johansson, G., Johansson, I. et al. Modifiable cardiovascular risk factors in patients with ankylosing spondylitis. Clin Rheumatol 33, 111–117 (2014). https://doi.org/10.1007/s10067-013-2410-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-013-2410-4

Keywords

Search

Navigation